Processa Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity, Disclosure: Schedule of Stock Option Activity (Tables)

12 Months Ended

Dec. 31, 2016

	Number of Options	Weighted Average Exercise Price	Weighted Average Remaining Life (Years)
Balance, December 31, 2014	1,246,500	$ 2.35	2.83
Granted	425,000	$ 1.50
Exercised	--	--
Cancelled	(1,080,333)	$ 2.33
Balance, December 31, 2015	591,167	$ 1.78	3.75
Exercisable, December 31, 2015	463,000	$ 1.76	3.68
Granted	--	--
Exercised	--	--
Cancelled	(321,667)	$ 1.69
Balance, December 31, 2016	269,500	$ 1.88	2.04
Exercisable, December 31, 2016	269,500	$ 1.88	2.04